Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective 5 February, while Chief Executive Officer Mark Alles will step up to assume the additional role of Chairman of the Board of Directors.
Celgene Executive Chairman Bob Hugin to retire
